J&J to cut 3000 jobs in medical devices unit


Healthcare giant Johnson & Johnson plans to eliminate around 3000 jobs from its medical devices operations. The cuts represent approximately 2.5% of the company’s global workforce, or 5% of the medical devices segment.

The redundancies will come from orthopaedic, surgical and cardiovascular device areas, while consumer medical devices, vision and diabetes businesses are unaffected. The company says it is restructuring to focus on areas in which it can be the number one or two player. The changes are intended to streamline its operations and ‘accelerate the pace of innovation’, while saving the company a projected $800 million (£560 million) a year.


Related Content

J&J to buy Vogue for haircare range

7 June 2016 Business

news image

$3.3bn deal expands Johnson & Johnson’s consumer products segment

Medical devices consolidation continues

4 February 2016 Business

news image

Abbott to buy Alere for $5.8bn to augment its point-of-care diagnostics business

Most Commented

Ethanol to butanol conversion shows sustainable potential

13 January 2016 Research

news image

Borrowed hydrogen chemistry drives reaction to obtain useful fuel from biomass

Israeli chemists urge government to ban chemical weapons

21 July 2016 News and Analysis

news image

Open letter presses prime minister to ‘remove the curse of chemical weapons from the face of the Earth’